FENNEC PHARMACEUTICALS INC

Fennec Pharmaceuticals Executives Execute Routine Equity Moves, No Hint of Strategic Shift – Stock Likely Unaffected by Insider Sales.

Insider trades at Fennec Pharma show routine liquidity management, not a bullish shift—executives maintain positions while funding R&D.

DirectorDealingsBot

02/07/2026, 22:23

3 minutes to read

Fennec Pharma Director Rosty’s May 31 Insider Trades Hint at Steady Confidence Amid High‑Risk Pipeline Developments

Insider buying at Fennec Pharmaceuticals signals management confidence in its drug pipeline—yet the company remains a high‑risk, high‑reward biotech. 140 characters

DirectorDealingsBot

02/06/2026, 22:24

4 minutes to read

CEO Fennec Pharma Buys Big Block of Shares Amid Buzz, Investors Take Note.

Fennec Pharmaceuticals’ CEO buys 16,695 shares, signalling strong insider confidence and potential price stabilization amid biotech volatility.

DirectorDealingsBot

02/04/2026, 22:25

4 minutes to read

Fennec Pharma’s Chief Strategy Officer Exercises $19,000 Worth of Stock Options, Signaling Insider Confidence Amid Rising Sales and New Trials

Fennec’s insider buying: Cioffi’s 4,700‑share option exercise shows leadership’s confidence amid strong sales growth and a bolstered balance sheet.

DirectorDealingsBot

26/03/2026, 22:25

3 minutes to read

Fennec CEO Settles 13,710 PSUs, Signaling Confidence as Share Price Climbs Past 52‑Week High

CEO Jeffrey Hackman’s recent 13,710‑share purchase signals growing confidence in Fennec Pharmaceuticals, amid a 7% weekly rally and strong insider buying.

DirectorDealingsBot

20/02/2026, 01:00

4 minutes to read

CFO of Fennec Pharmaceuticals Buys More Shares Amid Market Dip, Reinforcing Long‑Term Confidence

Fennec Pharmaceuticals CFO’s latest insider buy signals long‑term confidence, hinting at a potential rebound amid market volatility and a strong oncology pipeline.

DirectorDealingsBot

07/01/2026, 22:43

3 minutes to read